Healthcare > Diagnostics & Lab Services
•31 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (31)
| Company | Market Cap | Price |
|---|---|---|
|
LH
Labcorp Holdings Inc.
Labcorp operates a network of clinical laboratories delivering diagnostic testing services.
|
$22.07B |
$265.50
-0.05%
|
|
DGX
Quest Diagnostics Incorporated
Quest Diagnostics operates a nationwide network of clinical labs, i.e., clinical lab chains delivering diagnostic testing services.
|
$21.39B |
$190.97
-0.15%
|
|
EXAS
Exact Sciences Corporation
The company operates clinical laboratory testing capabilities as part of delivering its diagnostic products and services.
|
$19.10B |
$101.00
+0.09%
|
|
GH
Guardant Health, Inc.
Clinical Lab Chains: Guardant operates CLIA-certified lab operations to process tests.
|
$13.15B |
$111.05
+5.34%
|
|
TEM
Tempus AI, Inc.
Clinical Lab Chains – Tempus operates clinical laboratories delivering sequencing-based diagnostics, expanded by the Ambry Genetics acquisition.
|
$12.21B |
$74.94
+6.62%
|
|
DVA
DaVita Inc.
DaVita operates clinical laboratory testing facilities and diagnostic services as part of its dialysis and kidney care offerings.
|
$8.60B |
$120.17
-0.07%
|
|
HIMS
Hims & Hers Health, Inc.
Clinical laboratory chains / lab testing services through Trybe Labs.
|
$7.85B |
$37.90
+9.19%
|
|
SHC
Sotera Health Company
Nelson Labs operates clinical lab testing facilities, i.e., lab chains, as part of its testing services.
|
$4.64B |
$16.65
+1.96%
|
|
WGS
GeneDx Holdings Corp.
Clinical lab chains providing genetic testing services.
|
$4.21B |
$160.09
+9.24%
|
|
GRAL
GRAIL, Inc.
Company operates clinical laboratory testing capabilities to run Galleri and related studies.
|
$3.37B |
$110.22
+17.82%
|
|
ADPT
Adaptive Biotechnologies Corporation
Partnership activity with NeoGenomics reflects ADPT's role in clinical lab testing services / lab chains.
|
$2.83B |
$20.06
+7.79%
|
|
CON
Concentra Group Holdings Parent, Inc.
The business provides diagnostic testing via its clinics, aligning with laboratory testing and diagnostic service capabilities.
|
$2.59B |
$20.34
+0.57%
|
|
QDEL
QuidelOrtho Corporation
Clinical lab chains/diagnostic service networks align with QuidelOrtho’s lab-based business model and scale.
|
$1.65B |
$26.11
+7.23%
|
|
AZTA
Azenta, Inc.
Genewiz operates as a clinical lab network, aligning with Clinical Lab Chains.
|
$1.60B |
$36.38
+4.27%
|
|
NEO
NeoGenomics, Inc.
NeoGenomics operates a network of cancer-focused testing laboratories, i.e., clinical lab chains.
|
$1.48B |
$11.44
-0.39%
|
|
NEOG
Neogen Corporation
Genomics services and diagnostic testing capabilities may be organized or delivered through clinical lab networks, aligning with Clinical Lab Chains.
|
$1.24B |
$5.96
+4.11%
|
|
FLGT
Fulgent Genetics, Inc.
Company operates clinical lab chains providing diagnostic testing.
|
$918.27M |
$30.55
+1.82%
|
|
CDNA
CareDx, Inc
Operates as Clinical Lab Chains or core laboratory testing facilities providing diagnostic services.
|
$914.44M |
$17.99
+4.71%
|
|
MYGN
Myriad Genetics, Inc.
Clinical lab chains—multiplicity of testing locations and labs enabling national testing services.
|
$686.67M |
$7.74
+4.81%
|
|
SOPH
SOPHiA GENETICS S.A.
Clinical Lab Chains: target customers include clinical laboratories and networks leveraging the platform.
|
$301.63M |
$4.79
+5.40%
|
|
XGN
Exagen Inc.
Exagen’s core diagnostic testing capability places it within clinical lab chains as a diagnostic testing provider.
|
$167.45M |
$7.48
-1.71%
|
|
BNR
Burning Rock Biotech Limited
Operates clinical laboratory testing facilities (central lab/in-hospital model).
|
$147.10M |
$16.55
+16.14%
|
|
AKYA
Akoya Biosciences, Inc.
Clinical lab chains alignment with the company’s lab services and clinical testing offerings.
|
$64.26M |
$1.29
|
|
PRPO
Precipio, Inc.
Pathology/clinical lab services and diagnostic testing operations.
|
$39.68M |
$24.53
+0.12%
|
|
CDIX
Cardiff Lexington Corporation
Nova Ortho & Spine provides diagnostic and related assessment services, aligning with Diagnostics & Lab Services in Healthcare.
|
$10.98M |
$1.30
|
|
BNGO
Bionano Genomics, Inc.
BNGO has historically operated Clinical Lab Chains as part of its diagnostic services portfolio.
|
$7.58M |
$1.64
+0.93%
|
|
APM
Aptorum Group Limited
Diagnostics platform potentially operating as a network of clinical labs; reflects lab-based service delivery.
|
$7.11M |
$1.33
+2.31%
|
|
TRIB
Trinity Biotech plc
Operates Immco NYSDOH-certified clinical laboratory for diagnostic testing.
|
$6.36M |
$0.90
+8.35%
|
|
POAI
Predictive Oncology Inc.
CLIA-certified wet-lab operations and clinical-lab-style testing/validation services.
|
$4.71M |
$6.37
-1.70%
|
|
DFCO
Dalrada Financial Corporation
Boost Diagnostics provides diagnostic testing capabilities, consistent with clinical lab chains.
|
$4.21M |
$0.04
|
|
BIAF
bioAffinity Technologies, Inc.
The company operates clinical laboratory testing facilities as part of CyPath Lung, aligning with 'Clinical Lab Chains'.
|
$1.39M |
$1.48
+0.34%
|
Loading company comparison...
Loading industry trends...
Loading research report...
